Cellix Bio

About:

Cellix Bio provides medical research services to develop drug products for the treatment of immune and other related diseases.

Website: https://www.cellixbio.com/

Top Investors: Deepak Maheshwari

Description:

Cellix Bio provides medical research services to develop drug products for the treatment of immune and other related diseases. Cellix Bio's services are dedicated to the development of targeted therapies and proprietary molecular therapeutics that enhance the attributes of approved drugs, such as efficacy, therapeutic index, bioavailability, and safety, allowing healthcare professionals to treat chronic ailments faster and reduce recovery times.

Total Funding Amount:

$14.3M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Newark, New Jersey, United States

Founded Date:

2013-01-01

Contact Email:

info(AT)cellixbio.com

Founders:

Mahesh Kandula

Number of Employees:

11-50

Last Funding Date:

2019-04-02

IPO Status:

Private

Industries:

© 2025 bioDAO.ai